Missense mutations in hMLH1 associated with colorectal cancer

被引:60
作者
Liu, T
Tannergård, P
Hackman, P
Rubio, C
Kressner, U
Lindmark, G
Hellgren, D
Lambert, B
Lindblom, A [1 ]
机构
[1] Karolinska Inst, Dept Mol Med, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Novum, Ctr Biotechnol, Dept Biosci, S-14157 Huddinge, Sweden
[3] Karolinska Hosp, Dept Pathol, S-17176 Stockholm, Sweden
[4] Uddevalla Cent Hosp, Dept Surg, S-45180 Uddevalla, Sweden
[5] Univ Umea Hosp, Dept Surg, S-90185 Umea, Sweden
关键词
D O I
10.1007/s004390051127
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
One of the most prevalent hereditary syndromes associated with colorectal cancer is hereditary nonpolyposis colorectal cancer (HNPCC). The inherited gene defects in HNPCC have been shown to reside in DNA mismatch repair genes, mostly hMSH2 or hMLH1. Most HN-PCC patients are heterozygous with regard to the relevant mismatch repair gene; they have one normal and one mutated allele, and mismatch repair in normal somatic cells is functional. Cancer predisposition in HNPCC is believed to be associated with the loss of the wild-type allele in somatic cells, resulting in defective DNA mismatch repair. This gives rise to DNA microsatellite instability (MSI), an increased somatic mutation rate, and eventually to the accumulation of mutations in genes involved in colorectal carcinogenesis. In support of this theory, colorectal tumors in HNPCC patients and in mice deficient for hMSH2 or hMLH1 show MSI. Here, we describe two missense mutations in hMLH1 exon 16 associated with colorectal cancer. Interestingly, the tumors do not show MSI. This raises some potentially important issues. First, even microsatellite-negative colorectal tumors can be associated with germline mutations and these will be missed if an MST test is used to select patients for mutation screening. Second, the lack of MSI in these cases suggests that the mechanism involved in carcinogenesis could be different from that generally hypothesized.
引用
收藏
页码:437 / 441
页数:5
相关论文
共 37 条
[1]   CLUES TO THE PATHOGENESIS OF FAMILIAL COLORECTAL-CANCER [J].
AALTONEN, LA ;
PELTOMAKI, P ;
LEACH, FS ;
SISTONEN, P ;
PYLKKANEN, L ;
MECKLIN, JP ;
JARVINEN, H ;
POWELL, SM ;
JEN, J ;
HAMILTON, SR ;
PETERSEN, GM ;
KINZLER, KW ;
VOGELSTEIN, B ;
DELACHAPELLE, A .
SCIENCE, 1993, 260 (5109) :812-816
[2]  
Akiyama Y, 1997, CANCER RES, V57, P3920
[3]  
Boland CR, 1998, CANCER RES, V58, P5248
[4]   INACTIVATION OF THE MOUSE MSH2 GENE RESULTS IN MISMATCH REPAIR DEFICIENCY, METHYLATION TOLERANCE, HYPERRECOMBINATION, AND PREDISPOSITION TO CANCER [J].
DEWIND, N ;
DEKKER, M ;
BERNS, A ;
RADMAN, M ;
RIELE, HT .
CELL, 1995, 82 (02) :321-330
[5]  
Dietmaier W, 1997, CANCER RES, V57, P4749
[6]   Meiotic pachytene arrest in MLH1-deficient mice [J].
Edelmann, W ;
Cohen, PE ;
Kane, M ;
Lau, K ;
Morrow, B ;
Bennett, S ;
Umar, A ;
Kunkel, T ;
Cattoretti, G ;
Chaganti, R ;
Pollard, JW ;
Kolodner, RD ;
Kucherlapati, R .
CELL, 1996, 85 (07) :1125-1134
[7]   Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls [J].
Farrington, SM ;
Lin-Goerke, J ;
Ling, J ;
Wang, YT ;
Burczak, JD ;
Robbins, DJ ;
Dunlop, MG .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (03) :749-759
[8]   Microsatellite instability [J].
Frayling, IM .
GUT, 1999, 45 (01) :1-4
[9]   The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer [J].
Guerrette, S ;
Acharya, S ;
Fishel, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6336-6341
[10]   A human compound heterozygote for two MLH1 missense mutations [J].
Hackman, P ;
Tannergard, P ;
OseiMensa, S ;
Chen, JD ;
Kane, MF ;
Kolodner, R ;
Lambert, B ;
Hellgren, D ;
Lindblom, A .
NATURE GENETICS, 1997, 17 (02) :135-136